349 related articles for article (PubMed ID: 21810150)
1. Evaluation of the vancomycin dosage regimen based on serum creatinine used in the neonatal intensive care unit.
Irikura M; Fujiyama A; Saita F; Fukushima S; Kitaoka H; Fukuda T; Kawase A; Kondo Y; Ishitsuka Y; Kondo G; Maeda T; Yukawa E; Irie T
Pediatr Int; 2011 Dec; 53(6):1038-44. PubMed ID: 21810150
[TBL] [Abstract][Full Text] [Related]
2. Achievement of Therapeutic Vancomycin Trough Serum Concentrations with Empiric Dosing in Neonatal Intensive Care Unit Patients.
Ringenberg T; Robinson C; Meyers R; Degnan L; Shah P; Siu A; Sturgill M
Pediatr Infect Dis J; 2015 Jul; 34(7):742-7. PubMed ID: 25629890
[TBL] [Abstract][Full Text] [Related]
3. Cystatin C-Guided Vancomycin Dosing in Critically Ill Patients: A Quality Improvement Project.
Frazee E; Rule AD; Lieske JC; Kashani KB; Barreto JN; Virk A; Kuper PJ; Dierkhising RA; Leung N
Am J Kidney Dis; 2017 May; 69(5):658-666. PubMed ID: 28131530
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of vancomycin dosing regimens in preterm and term neonates using Monte Carlo simulations.
Mehrotra N; Tang L; Phelps SJ; Meibohm B
Pharmacotherapy; 2012 May; 32(5):408-19. PubMed ID: 22488303
[TBL] [Abstract][Full Text] [Related]
5. An evaluation of vancomycin dosing for complicated infections in pediatric patients.
Durham SH; Simmons ML; Mulherin DW; Foland JA
Hosp Pediatr; 2015 May; 5(5):276-81. PubMed ID: 25934812
[TBL] [Abstract][Full Text] [Related]
6. Association between vancomycin trough concentration and area under the concentration-time curve in neonates.
Frymoyer A; Hersh AL; El-Komy MH; Gaskari S; Su F; Drover DR; Van Meurs K
Antimicrob Agents Chemother; 2014 Nov; 58(11):6454-61. PubMed ID: 25136027
[TBL] [Abstract][Full Text] [Related]
7. Empirical Vancomycin Dosing in Pediatric Patients with Congenital Heart Disease and the Impact of Cardiopulmonary Bypass on Trough Concentrations.
Thomas CA; Picone A; Menon S; Willis BC
Pharmacotherapy; 2017 Nov; 37(11):1341-1346. PubMed ID: 28833385
[TBL] [Abstract][Full Text] [Related]
8. A retrospective analysis of possible renal toxicity associated with vancomycin in patients with health care-associated methicillin-resistant Staphylococcus aureus pneumonia.
Jeffres MN; Isakow W; Doherty JA; Micek ST; Kollef MH
Clin Ther; 2007 Jun; 29(6):1107-15. PubMed ID: 17692725
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of vancomycin target trough attainment with published dosing regimens in the neonatal intensive care unit population.
Chung E; Lee SE; Abraham T; Saad NN; Gad A
J Neonatal Perinatal Med; 2019; 12(1):21-27. PubMed ID: 30149480
[TBL] [Abstract][Full Text] [Related]
10. Vancomycin Therapeutic Regime Adjustment in Newborns and Infants with Bacterial Infection: Case Series.
Bidu NS; Fernandes BJD; Dias EJC; Filho JNC; Bastos REA; Godoy ALPC; Azeredo FJ; Pedreira JNR; Couto RD
Curr Pharm Biotechnol; 2019; 20(4):346-351. PubMed ID: 30892160
[TBL] [Abstract][Full Text] [Related]
11. Vancomycin population pharmacokinetics in neonates.
de Hoog M; Schoemaker RC; Mouton JW; van den Anker JN
Clin Pharmacol Ther; 2000 Apr; 67(4):360-7. PubMed ID: 10801244
[TBL] [Abstract][Full Text] [Related]
12. Vancomycin prescription in neonates and young infants: toward a simplified dosage.
Oudin C; Vialet R; Boulamery A; Martin C; Simon N
Arch Dis Child Fetal Neonatal Ed; 2011 Sep; 96(5):F365-70. PubMed ID: 21378399
[TBL] [Abstract][Full Text] [Related]
13. The Effectiveness of a Vancomycin Dosing Guideline in the Neonatal Intensive Care Unit for Achieving Goal Therapeutic Trough Concentrations.
Reilly AM; Ding MX; Rower JE; Kiser TH
J Clin Pharmacol; 2019 Jul; 59(7):997-1005. PubMed ID: 30776089
[TBL] [Abstract][Full Text] [Related]
14. Predictors of mortality for methicillin-resistant Staphylococcus aureus health-care-associated pneumonia: specific evaluation of vancomycin pharmacokinetic indices.
Jeffres MN; Isakow W; Doherty JA; McKinnon PS; Ritchie DJ; Micek ST; Kollef MH
Chest; 2006 Oct; 130(4):947-55. PubMed ID: 17035423
[TBL] [Abstract][Full Text] [Related]
15. [Optimalisation of netilmicin dosage based on therapeutic drug monitoring during the first days of life in very preterm neonates (gestational age 23-32 weeks)].
Rutkowska M; Kamińska E; Piekarczyk A; Nowicka K; Polak K; Nowakowska-Szyrwińska E; Szamotulska K
Med Wieku Rozwoj; 2009; 13(4):252-9. PubMed ID: 20081273
[TBL] [Abstract][Full Text] [Related]
16. Vancomycin dosage requirements among pediatric intensive care unit patients with normal renal function.
Glover ML; Cole E; Wolfsdorf J
J Crit Care; 2000 Mar; 15(1):1-4. PubMed ID: 10757191
[TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetics of vancomycin in neonates admitted to the neonatology unit at the Jordan University Hospital.
Badran EF; Shamayleh A; Irshaid YM
Int J Clin Pharmacol Ther; 2011 Apr; 49(4):252-7. PubMed ID: 21429439
[TBL] [Abstract][Full Text] [Related]
18. Modified vancomycin dosing protocol for treatment of diabetic foot infections.
Niu SC; Deng ST; Lee MH; Ho C; Chang HY; Liu FH
Am J Health Syst Pharm; 2008 Sep; 65(18):1740-3. PubMed ID: 18769001
[TBL] [Abstract][Full Text] [Related]
19. Assessment of vancomycin dosing and subsequent serum concentrations in pediatric patients.
Eiland LS; English TM; Eiland EH
Ann Pharmacother; 2011 May; 45(5):582-9. PubMed ID: 21521865
[TBL] [Abstract][Full Text] [Related]
20. Protocol versus Nonprotocol Dosing of Vancomycin in Neonates: A Single Center Evaluation of Steady State Trough Levels.
Schwartz ML; Wrobel J; Huntley J; Zeilmann C
Am J Perinatol; 2016 Jun; 33(7):678-82. PubMed ID: 26862722
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
